E-DRUG: Report: Advocates Demand Greater Public Returns From EC's R&D program
-------------------------------------------------------------------------------------------------------
Dear e-druggers,
Report: European Public Health Advocates Demand Greater Public Returns From European Commission¹s Research and Development Programme, Horizon 2020
Health Action International has today released a joint position paper
calling upon the European Commission to make substantial changes to how it
funds research and development (R&D) projects for new medicines, to allow
for greater public access to the innovations that it helps to fund. The
position paper particularly focuses on the EU's R&D programme, Horizon
2020, which administers a funding pool of near 80 billion Euro.
The position paper also echoes many of the demands made on Tuesday by the
European Parliament Committee on Environment, Public Health and Food
Safety.
The paper was co-authored by Health Action International, Medecins Sans
Frontieres - Access Campaign, Global Health Advocates, Commons Network,
Universities Allied for Essential Medicines, Salud for Derecho, Knowledge
Ecology International – Europe and BukoPharmaKampagne.
To read the full report, go to
http://bit.ly/2jYEAly
The media release is available below and at
http://bit.ly/2ktaY3e.
Kind regards,
James Still
Communications Advisor
Health Action International
Overtoom 60-2, 1054 HK Amsterdam, The Netherlands
Phone: + 31 (0) 20 412 4523
www.haiweb.org